Sectors
Tokai Pharma Signs US$35.5M in Series E
Tokai Pharma receives US$35.5 series E capital financing round. Tokai Pharmaceuticals, Inc announced today that it was able to secure US$35. 5 million in a round of Series E growth financing in order to persuade investors to support Tokai's lead prostate cancer pharmaceutical product currently in medical development.
Inter RAO Lietuva AB reported Net Loss for First Quarter
Inter RAO Lietuva AB reported loss for 2013 first quarter post IPO. Since its trading on the Warsaw bourse last December, Inter RAO Lietuva AB share values has slumped since it reported a 52% drop in its 2013 first quarter.
Bayside Capital Invests in Consolis
Bayside Capital and LBO France invest in Consolis. In an announcement today by Bayside Capital, it disclosed that a venture fund administered by Bayside had concluded a venture in Consolis, a renowned European producer of assembled concrete products.
Larsen and Toubro to Sell Inflation Linked Bonds
Larsen and Toubro, following the lead of the Singh government, is selling inflation pegged bonds to the market.




